Auto-generated: February 12 2012 07:15 PM GMT-8

461
Stars
Star This?

Source: DGNews  |  Posted 9 years ago

Acetylcysteine Can Reduce Cardiovascular Events in Patients with Endstage Renal Disease

By Peggy Peck
Special to DG News

ORLANDO, FL -- October 1, 2002 -- Antioxidant therapy with acetylcysteine appears to significantly reduce cardiovascular events among haemodialysis patients.

The research was presented here Sept. 30 at the American Heart Association's 56th Annual Fall Conference and Scientific Sessions of the Council on High Blood Pressure Research.

Markus van der Giet, MD of Freie Universit

461
Stars
Star This?  Yes / No
 
Sign InSign In
inst val